2019 ESC Guidelines for the Diagnosis and Management of Acute Pulmonary Embolism: Habemus (Novam) Lex!
References
- 1. Guyatt GH. Evidence-based medicine. ACP J Club 1991; 114: A16.10.7326/ACPJC-1991-114-2-A16
- 2. Sehon SR, Stanley DE. A philosophical analysis of the evidence-based medicine debate. BMC Health Services Research 2003; 3: 14.10.1186/1472-6963-3-1416918712873351
- 3. Konstantinides SV, Meyer G, Becattini C et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS) The Task Force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC). Eur Heart J 2019; 00: 161 doi:10.1093/eurheartj/ehz405.10.1093/eurheartj/ehz40531504429
- 4. Beydilli İ, Yılmaz F, Sönmez BM, et al. Thrombolytic therapy delay is independent predictor of mortality in acute pulmonary embolism at emergency service. Kaohsiung J Med Sci 2016; b32 (11): b572-578.10.1016/j.kjms.2016.09.00427847100
- 5. Agnelli G, Becattini C, Bauersachs R, et al. Apixaban versus dalteparin for the treatment of acute venous thromboembolism in patients with cancer: The Caravaggio Study. Thromb Haemost 2018; 118(9): 1668-1678.10.1055/s-0038-166852330103252
- 6. Napolitano M, Saccullo G, Malato A, et al. Optimal duration of low molecular weight heparin for the treatment of cancer-related deep vein thrombosis: the Cancer-DACUS Study. J Clin Oncol 2014; 32: 3607-3612.10.1200/JCO.2013.51.743325267738
- 7. Rosovsky R, Borges J, Kabrhel C, Rosenfield K. Pulmonary embolism response team: inpatient structure, outpatient follow-up, and is it the current standard of care? Clin Chest Med 2018; 39: 62130.
Language: English
Page range: 63 - 66
Published on: Mar 12, 2020
Published by: Romanian Society of Internal Medicine
In partnership with: Paradigm Publishing Services
Publication frequency: 4 times per year
Keywords:
Related subjects:
© 2020 Antoniu Octavian Petriş, published by Romanian Society of Internal Medicine
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.